CAS: 306-20-7 - fenaclon
Fórmula:C11H14ClNO
InChI:InChI=1S/C11H14ClNO/c12-8-6-11(14)13-9-7-10-4-2-1-3-5-10/h1-5H,6-9H2,(H,13,14)
Clave InChI:InChIKey=BITWVVLBVUMFHU-UHFFFAOYSA-N
SMILES:O=C(NCCC=1C=CC=CC1)CCCl
- Sinónimos:
- 3-Chloro-N-phenethylpropionamide
- 3-chloro-N-(2-phenylethyl)propanamide
- Brn 2939383
- Fenaclon [INN]
- Fenaclona
- Fenaclona [INN-Spanish]
- Fenaclone
- Fenaclone [INN-French]
- Fenaclonum
- Fenaclonum [INN-Latin]
- Ver más sinónimos
- Fenakon
- N-(2-Phenethyl)-3-chloropropionamide
- Phenacon
- Phenacone
- Propanamide, 3-chloro-N-(2-phenylethyl)-
- Propanamide, 3-chloro-N-(2-phenylethyl)- (9CI)
- Propionamide, 3-chloro-N-(phenethyl)-
- Unii-6M4Ir9Qy13
- β-Chloro-N-phenethylpropionamide
- β-Chloropropio-N-phenylethylamide
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
Fenaclon REF: TM-T8604CAS: 306-20-7 | 99.54% | 54,00 €~385,00 € | Lun 29 Jul 24 | |
3-Chloro-N-phenethyl-propionamide REF: 10-F026351CAS: 306-20-7 | 95.0% | A consultar | Mar 30 Jul 24 | |
3-Chloro-N-phenethyl-propionamide REF: 3D-AAA30620CAS: 306-20-7 | Min. 95% | A consultar | Mar 03 Sep 24 |
Fenaclon
CAS:306-20-7
Fenaclon (Fenaclonum) is an anticonvulsant. It is indicated for the treatment of epilepsy.
Fórmula:
C11H14ClNO
Pureza:
99.54%
Forma y color:
Solid
Peso molecular:
211.69
Ref: TM-T8604
1ml | 81,00 € | ||
2mg | 54,00 € | ||
5mg | 78,00 € | ||
10mg | 98,00 € | ||
25mg | 171,00 € | ||
50mg | 257,00 € | ||
100mg | 385,00 € |
Entrega estimada en Estados Unidos, el Lunes 29 de Julio de 2024
Ref: 10-F026351
1g | A consultar | ||
2.5g | A consultar | ||
250mg | A consultar | ||
500mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 30 de Julio de 2024
3-Chloro-N-phenethyl-propionamide
CAS:306-20-7
3-Chloro-N-phenethyl-propionamide is a hydrophobic, insoluble, and implanting drug that can be reconstituted with water and …
Fórmula:
C11H14ClNO
Pureza:
Min. 95%
Peso molecular:
211.69 g/mol
Ref: 3D-AAA30620
1g | 1.050,00 € | ||
100mg | 281,00 € |
Entrega estimada en Estados Unidos, el Martes 3 de Septiembre de 2024